PATRIARCA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.606
NA - Nord America 1.202
AS - Asia 1.149
SA - Sud America 143
AF - Africa 43
OC - Oceania 9
Totale 4.152
Nazione #
US - Stati Uniti d'America 1.149
RU - Federazione Russa 474
SG - Singapore 461
IT - Italia 320
IE - Irlanda 260
CN - Cina 180
VN - Vietnam 169
HK - Hong Kong 146
DE - Germania 145
SE - Svezia 121
BR - Brasile 103
FR - Francia 76
IN - India 54
FI - Finlandia 50
GB - Regno Unito 42
CA - Canada 32
UA - Ucraina 29
KR - Corea 23
ID - Indonesia 19
MX - Messico 19
TR - Turchia 18
BD - Bangladesh 17
BJ - Benin 17
PL - Polonia 16
AR - Argentina 14
NL - Olanda 14
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
ES - Italia 10
LT - Lituania 10
AU - Australia 9
IR - Iran 9
PK - Pakistan 9
AT - Austria 7
CL - Cile 6
JP - Giappone 6
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
SA - Arabia Saudita 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
PE - Perù 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
YE - Yemen 1
Totale 4.152
Città #
Dublin 253
San Jose 183
Hong Kong 146
Singapore 133
Ashburn 113
Piemonte 70
Chandler 66
Los Angeles 60
Beijing 57
Novara 57
Ho Chi Minh City 43
Munich 42
Moscow 41
Helsinki 40
Lauterbourg 39
Hanoi 36
Jacksonville 33
New York 32
Orem 28
Lawrence 25
Princeton 25
Boardman 24
Council Bluffs 24
Bremen 21
Seoul 21
Chennai 18
Frankfurt am Main 18
Buffalo 17
Cotonou 17
Santa Clara 17
São Paulo 17
Toronto 17
San Mateo 16
Falkenstein 14
Genoa 13
Grafing 13
Haiphong 13
London 13
Wilmington 13
Turin 12
Atlanta 11
Dallas 11
Jakarta 11
Montreal 11
Warsaw 11
Guangzhou 10
Mexico City 10
Nuremberg 10
Strasbourg 10
Turku 10
Brno 9
Brooklyn 9
Milan 9
Phoenix 9
Poplar 9
Dong Ket 8
Houston 8
Redondo Beach 8
Stockholm 8
Sydney 8
Amsterdam 7
Andover 7
Da Nang 7
Johannesburg 7
Assago 6
Rome 6
Shanghai 6
Tokyo 6
Ankara 5
Bexley 5
Boston 5
Chicago 5
Mumbai 5
New Delhi 5
Vercelli 5
Bologna 4
Dalian 4
Denver 4
Islamabad 4
Istanbul 4
Santiago 4
Tianjin 4
Vienna 4
West Jordan 4
Addis Ababa 3
Baku 3
Barnet 3
Belgrade 3
Belo Horizonte 3
Berlin 3
Brussels 3
Charlotte 3
Leawood 3
Milwaukee 3
Mülheim 3
Norwalk 3
Paris 3
Phủ Lý 3
Querétaro 3
Quito 3
Totale 2.201
Nome #
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 222
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 221
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 132
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 130
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 126
Targeting p53 in chronic lymphocytic leukemia 121
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 119
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 118
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 117
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 116
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 116
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 114
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 114
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 113
Precision medicine management of chronic lymphocytic leukemia 109
Atypical chronic myeloid leukemia: Where are we now? 108
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 108
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 107
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 106
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 102
Precision Medicine in Systemic Mastocytosis 102
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 99
A step ahead toward precision medicine for chronic lymphocytic leukemia 97
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 95
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 94
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 94
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 94
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 94
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies 89
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia 88
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 88
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 87
A phase 3 study of pelebresib plus ruxolitinib for JAK inhibitor-naive patients with myelofibrosis 83
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 83
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 81
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab 79
Prescription patterns of venetoclax in acute myeloid leukemia 74
Intravascular lymphoma: from vessels to genes 53
Investigational drugs for the treatment of diffuse large B-cell lymphoma 51
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report 37
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a ZRSR2 Mutation 26
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study 23
Totale 4.230
Categoria #
all - tutte 19.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 21 24 11
2021/2022274 7 4 21 34 18 10 23 13 13 36 50 45
2022/2023543 46 22 47 4 35 47 25 20 250 3 25 19
2023/2024269 27 23 23 7 38 9 36 6 4 5 37 54
2024/2025824 21 19 43 10 28 30 47 138 124 51 113 200
2025/20262.159 116 76 121 273 263 164 371 409 187 179 0 0
Totale 4.230